Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
Taiwan · Delayed Price · Currency is TWD 38.75
+3.50 (9.93%)
May 8, 2026, 1:23 PM CST
TPE:1762 Revenue
In the year 2025, Chunghwa Chemical Synthesis & Biotech had annual revenue of 804.88M TWD, down -40.26%. Chunghwa Chemical Synthesis & Biotech had revenue of 113.42M in the quarter ending December 31, 2025, a decrease of -60.39%.
Revenue
804.88M
Revenue Growth
-40.26%
P/S Ratio
3.70
Revenue / Employee
4.07M
Employees
198
Market Cap
2.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 804.88M | -542.50M | -40.26% |
| Dec 31, 2024 | 1.35B | -739.07M | -35.42% |
| Dec 31, 2023 | 2.09B | -30.70M | -1.45% |
| Dec 31, 2022 | 2.12B | 182.44M | 9.43% |
| Dec 31, 2021 | 1.93B | 391.11M | 25.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.07B |
| Apex Biotechnology | 1.94B |
| SYN-TECH Chem. & Pharm. | 1.30B |
| Genovate Biotechnology | 492.41M |
| HeXun Biosciences | 293.23M |
| BioGend Therapeutics | 229.81M |
| Intech Biopharm | 107.53M |
| Shine-On BioMedical | 30.00M |